Jincai Luo

2.1k citations
34 papers · 1.3k indexed · h-index 17
Topics
Angiogenesis and VEGF in Cancer (9 papers)Protein Tyrosine Phosphatases (5 papers)Platelet Disorders and Treatments (4 papers)
Partner nations
ChinaUnited StatesJapan

In The Last Decade

Jincai Luo

33 papers receiving 1.3k citations

Peers

Jincai Luo
Comparison fields: 5 of 114
  • Molecular Biology 810
  • Immunology 312
  • Oncology 248
  • Cell Biology 161
  • Physiology 109
Replace Julius O. Ebinu with:
Julius O. Ebinu United States
Rosana Meyer United States
Wenyan Miao United States
Kenneth R. LaMontagne United States
Federico Galvagni Italy
Muriel Busson France
Daniel L. Altschuler United States
Laura Gualandi Sweden
Helen Kotanides United States
Pamela Das United Kingdom
Jincai Luo relative to Julius O. Ebinu United States Julius O. Ebinu's profile →
Citations per field
00.5×
Julius O. Ebinu · 1×
Citations per year

Countries citing papers authored by Jincai Luo

Since Specialization
Citations

This map shows the geographic impact of Jincai Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jincai Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jincai Luo more than expected).

Fields of papers citing papers by Jincai Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jincai Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jincai Luo. The network helps show where Jincai Luo may publish in the future.

Co-authorship network of co-authors of Jincai Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Jincai Luo. A scholar is included among the top collaborators of Jincai Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jincai Luo. Jincai Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 2
2 1
3 9
4 4
5 3
6 4
7 45
8 4
9 1
10 16
11 18
12 32
13 84
14 58
15 21
16 9
17 53
18 68
19 369
20 32

About Jincai Luo

Jincai Luo is a scholar working on Hematology, Molecular Biology and Immunology, having authored 34 papers that have together received 1.3k indexed citations. Recurring topics across this work include Angiogenesis and VEGF in Cancer (9 papers), Protein Tyrosine Phosphatases (5 papers) and Platelet Disorders and Treatments (4 papers). The work is most often cited by research in Immunology and Allergy (98 citations), Immunology (312 citations) and Molecular Biology (810 citations). Jincai Luo has collaborated with scholars based in China, United States and Japan. Frequent co-authors include Yan Xiong, Wentian Yang, Benjamin G. Neel, Yingqing Huo, Mark R. Philips, Maria Kontaridis, Trever G. Bivona, Julie Thompson, Burkhart Schraven and Gengyun Wen. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026